No correlation between phaeochromocytoma catecholamine secretion and granule ultrastructure

British Journal of Surgery

Volumn 85, Issue 12, 1998, Pages 1681-1685

  Mihai, R ^a   Wong, N A C S ^a   Luckett, M ^a   Sheffield, E ^a   Farndon, J R ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BIOCHEMICAL MARKER; CATECHOLAMINE; DOPAMINE; NORADRENALIN;

ADOLESCENT; ADRENALIN RELEASE; ADULT; AGED; ARTICLE; CATECHOLAMINE RELEASE; CLINICAL ARTICLE; DOPAMINE RELEASE; ELECTRON MICROSCOPY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NORADRENALIN RELEASE; PARAGANGLIOMA; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SECRETORY GRANULE; URINE LEVEL;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGED; CATECHOLAMINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOPLASMIC GRANULES; DOPAMINE; EPINEPHRINE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; NOREPINEPHRINE; PHEOCHROMOCYTOMA; PROSPECTIVE STUDIES;

EID: 0031736049     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.1998.00965.x     Document Type: Article

References (17)

1. Frankel F. Ein fall von doppelseitigen vollig latent verlaufen nehenierentumour und gleichseitiger nephritis mit Veranderungen am circulation suppart and retinitis. Virchows Archives 1886; 103: 224.
2. Pick L. Das gangliona embrionale sympaticum. Klin Wochenschr 1912; 19: 16.
3. Oliver G, Sharpey-Schafer EA. The physiological effects of extracts of the suprarenal capsules. J Physiol (Lond) 1895; 18: 230.
4. Stolz F. Ueher Adrenalin und Alkylaminoacetobenzcatechin. Deutsche Chem Ges 1904; 37: 41-9.
5. Kohayashi C, Coupland RE. Morphological aspects of chromaffin tissue: the differential fixation of adrenaline and noradrenaline. J Anat 1993; 183: 223-35.
6. Henderson DW, Papadimitriou JM (eds). Ultrastructural Appearances of Tumours - A Diagnostic Atlas. Edinburgh: Churchill Livingstone, 1982: 148-9.
7. Ghadially FN (ed.). Diagnostic Electron Microscopy of Tumours. London: Butterworth, 1980: 98-9.
8. Tannenbaum M. Ultrastructural pathology of adrenal medullary tumors. Pathol Annu 1970; 5: 145.
9. Furihata M, Hikita T, Iwata J, Mizobuchi H, Sonobe H, Ohtsuki Y. Ultrastructural observation of three cases of adrenal phaeochromocytomas. Journal of Clinical Electron Microscopy 1989; 22: 5-6.
10. Gomez RR, Osborne BM, Ordonez NG, Mackay B. Pheochromocytoma. Ultrastruct Pathol 1991; 15: 557-62.
11. Fraga M, Garcia Caballero T, Antunez J, Couoce M, Beiras A, Forteza J. A comparative immunohistochemical study of phaeochromocytomas and paragangliomas. Histology and Histopathology 1993; 8: 429-36.
12. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD (eds). The Molecular Biology of the Cell. New York: Garland, 1994: 626-30.
13. Montresor E, Iacono C, Nifosi F, Zanza A, Modena S, Zamboni G et al. Retroperitoneal paraglangliomas - role of immunocytochemistry in the diagnosis of malignancy and in assessment of prognosis. Eur J Surg 1994; 160: 547-52.
14. Ross GA, Newbould EC, Thomas J, Bouloux PMG, Besser GM, Perrett D et al. Plasma and 24 h-urinary catecholamine concentrations in normal and patient populations. Ann Clin Biochem 1993; 30: 38-44.
15. Bravo EL, Gifford RW Jr, Goldfarb D. Current perspectives in the diagnosis and management of phaeochromocytomas. Endo Rel Cancer 1996; 3: 293-308.
16. Farndon JR, Davidson HA, Johnston IDA, Wells SA. VMA extraction in patients with pheochromocytoma. Ann Surg 1980; 191: 259-63.
17. Crout JR, Sjoerdsma A. Turnover and metabolism of catecholamine in patients with phaeochromocytoma. J Clin Invest 1964; 43: 94-102.